Condition
Bietti Crystalline Corneoretinal Dystrophy
Total Trials
4
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 3 (1)
Trial Status
Active Not Recruiting2
Enrolling By Invitation1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06706427Phase 1Active Not RecruitingPrimary
Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects
NCT06743646Phase 3Active Not RecruitingPrimary
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT07307469Not ApplicableEnrolling By InvitationPrimary
Compassionate Administration of ZVS101e for Extended Treatment
NCT07653971Not ApplicableNot Yet Recruiting
ZVS101e in Patients With Bietti's Crystalline Dystrophy
Showing all 4 trials